Our top pick for
TSR Inc is a software-application business based in the US. TSR shares (TSRI) are listed on the NASDAQ and all prices are listed in US Dollars. TSR employs 606 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.75|
|52-week range||$5.02 - $16.80|
|50-day moving average||$10.47|
|200-day moving average||$9.41|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.94|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||17.36%|
|1 month (2021-09-17)||-8.51%|
|3 months (2021-07-19)||1.32%|
|6 months (2021-04-19)||35.39%|
|1 year (2020-10-19)||112.03%|
|2 years (2019-10-18)||222.83%|
|3 years (2018-10-19)||62.07%|
|5 years (2016-10-19)||91.96%|
Valuing TSR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TSR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TSR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, TSR shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
TSR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $522,927.
The EBITDA is a measure of a TSR's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$77.2 million|
|Operating margin TTM||0.4%|
|Gross profit TTM||$11.3 million|
|Return on assets TTM||0.93%|
|Return on equity TTM||65.88%|
|Market capitalisation||$19.7 million|
TTM: trailing 12 months
There are currently 6,746 TSR shares held short by investors – that's known as TSR's "short interest". This figure is 53.1% down from 14,381 last month.
There are a few different ways that this level of interest in shorting TSR shares can be evaluated.
TSR's "short interest ratio" (SIR) is the quantity of TSR shares currently shorted divided by the average quantity of TSR shares traded daily (recently around 224866.66666667). TSR's SIR currently stands at 0.03. In other words for every 100,000 TSR shares traded daily on the market, roughly 30 shares are currently held short.
However TSR's short interest can also be evaluated against the total number of TSR shares, or, against the total number of tradable TSR shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TSR's short interest could be expressed as 0% of the outstanding shares (for every 100,000 TSR shares in existence, roughly 0 shares are currently held short) or 0.0103% of the tradable shares (for every 100,000 tradable TSR shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against TSR.
Find out more about how you can short TSR stock.
We're not expecting TSR to pay a dividend over the next 12 months.
TSR's shares were split on a 1:2 basis on 29 November 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TSR shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for TSR shares which in turn could have impacted TSR's share price.
Over the last 12 months, TSR's shares have ranged in value from as little as $5.02 up to $16.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TSR's is 1.0725. This would suggest that TSR's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
TSR, Inc. , a staffing company, focuses on recruiting information technology (IT) professionals for short- and long-term assignments, permanent placements, project work, and providing contract computer programming services to its customers in the New York metropolitan area, New England, and the Mid-Atlantic region. The company provides technical computer personnel to supplement the in-house IT capabilities of its customers in the areas of . net and java, mobile applications for Android and IOS platforms, project management, IT security specialists, cloud development and architecture, business analysts, UI design and development, network infrastructure and support, and database development and administration. It primarily serves vendor management companies, as well as customers in the financial services business. The company was incorporated in 1969 and is based in Hauppauge, New York. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.